SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ANDRX (ADRX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: PAUL ROBERT ST. ONGE who wrote (64)4/22/1998 12:33:00 AM
From: PAUL ROBERT ST. ONGE   of 127
 
Patent expires in Canada year 2000, 2001 here. I am sure Astra-Merck would want to cut a deal as this would allow them to secure their product for years to come. Worst case scenario, Andrx licenses the patent, uses an alternative, or waits to launch.

Still pure upside!

Product could be launched a year earlier in Canada, which does make it shrink the time frame.

If Astra-Merck does not sue, then a deal would be likely.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News